From the Editor-in-Chief: "Therapeutic Glyco-Proteins Produced by Living Organisms" or "Drugs"?
BioProcessing Journal · 27.07.2026 · 3
DOI: 10.12665/j122.carson ↗Kurz gefasst
Fachartikel in der Zeitschrift BioProcessing Journal, online erschienen am 27.07.2026. Verfasst von Keith L. Carson.
Abstract (Originalsprache)
"But why are they calling these products 'drugs?'” I asked at the recent CMC Strategy meeting that CaSSS hosted in Gaithersburg. “Well it’s because they aren’t vaccines or blood products” said an old friend, who is an authority in the field. “But,” I said, “we’re really talking about therapeutic glyco-proteins produced by living organisms.” And just to make sure I was remembering things correctly, I searched Google and reviewed the definitions for a “biologic” and “biological” in several of the top technical references. Truly, a biologic or biological is a substance produced by a living organism, which would include glyco-proteins, non-glycosylated proteins, enzymes, viruses, and broken up proteins which could be used as poly-peptides or simple antigens...
Zitieren
APA
Carson, K. L. (2026). From the Editor-in-Chief: "Therapeutic Glyco-Proteins Produced by Living Organisms" or "Drugs"?. BioProcessing Journal, 3. https://doi.org/10.12665/j122.carson
Vancouver
Carson KL. From the Editor-in-Chief: "Therapeutic Glyco-Proteins Produced by Living Organisms" or "Drugs"?. BioProcessing Journal. 2026:3. doi:10.12665/j122.carson
BibTeX
@article{Carson2026,
author = {Carson, Keith L.},
title = {From the Editor-in-Chief: "Therapeutic Glyco-Proteins Produced by Living Organisms" or "Drugs"?},
journal = {BioProcessing Journal},
year = {2026},
pages = {3},
doi = {10.12665/j122.carson}
}
EUVIMED